Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-07-01 | Ms. Terilyn Juarez MonroeCPO | -2,10k | 358,45k | Derivative Exercise and Sale | 170,77 | 22,98k | - |
| 2026-07-01 | Ms. Terilyn Juarez MonroeCPO | 1,92k | 0,00 | Derivative Exercise and Retained Stock | - | 22,98k | 9,12% |
| 2026-07-01 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -3,71k | 633,04k | Derivative Exercise and Sale | 170,77 | 39,79k | - |
| 2026-07-01 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | 3,36k | 0,00 | Derivative Exercise and Retained Stock | - | 39,79k | 9,21% |
| 2026-07-01 | Mr. Kumud KaliaChief Information Officer | -3,07k | 523,58k | Derivative Exercise and Sale | 170,77 | 43,79k | - |
| 2026-07-01 | Mr. Kumud KaliaChief Information Officer | 2,98k | 0,00 | Derivative Exercise and Retained Stock | - | 43,79k | 7,30% |
| 2026-07-01 | Dr. Darya ChudovaCTO | -4,32k | 737,38k | Derivative Exercise and Sale | 170,77 | 87,91k | - |
| 2026-07-01 | Dr. Darya ChudovaCTO | 3,71k | 0,00 | Derivative Exercise and Retained Stock | - | 87,91k | 4,41% |
| 2026-07-01 | Mr. Christopher FreemanChief Commercial Officer of Oncology | -3,14k | 536,39k | Derivative Exercise and Sale | 170,77 | 65,37k | - |
| 2026-07-01 | Mr. Christopher FreemanChief Commercial Officer of Oncology | 4,27k | 0,00 | Derivative Exercise and Retained Stock | - | 65,37k | 6,99% |
| 2026-06-30 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | -18,51k | 3,13M | Derivative Exercise and Sale | 150,03 - 170,77 | 2,36M | - |
| 2026-06-30 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | 18,02k | 0,00 | Derivative Exercise and Retained Stock | - | 2,36M | 0,77% |
| 2026-07-01 | Mr. Michael BellCFO | -3,91k | 668,39k | Derivative Exercise and Sale | 170,77 | 51,82k | - |
| 2026-07-01 | Mr. Michael BellCFO | 3,36k | 0,00 | Derivative Exercise and Retained Stock | - | 51,82k | 6,94% |
| 2026-06-30 | Dr. AmirAli TalasazCo-CEO & Director | -18,51k | 3,13M | Derivative Exercise and Sale | 150,03 - 170,77 | 1,90M | - |
| 2026-06-30 | Dr. AmirAli TalasazCo-CEO & Director | 18,02k | 0,00 | Derivative Exercise and Retained Stock | - | 1,90M | 0,96% |
| 2026-06-30 | Mr. Steve Edward KrognesIndependent Director | 155,00 | 0,00 | Derivative Exercise and Retained Stock | - | 14,58k | 1,07% |
| 2026-06-10 | Mr. Kumud KaliaChief Information Officer | -1,20k | 157,16k | Vendita | 130,86 - 131,08 | 40,81k | -2,86% |
| 2026-06-15 | Mr. Kumud KaliaChief Information Officer | 600,00 | 78,46k | Acquisto | 130,76 | 40,81k | 1,49% |
| 2026-06-26 | Dr. AmirAli TalasazCo-CEO & Director | -5,17k | 781,19k | Vendita | 151,16 | 1,88M | -0,27% |
| 2026-06-26 | Dr. AmirAli TalasazCo-CEO & Director | -254,83k | 37,47M | Derivative Exercise and Sale | 4,18 - 153,00 | 1,88M | - |
| 2026-06-22 | Mr. Musa TariqIndependent Director | -1,95k | 255,89k | Vendita | 131,16 | 11,05k | -15,01% |
| 2026-06-22 | Ms. Myrtle S. PotterIndependent Director | -1,56k | 204,08k | Vendita | 131,16 | 20,97k | -6,91% |
| 2026-05-21 | Mr. Roberto Agostino MignoneIndependent Director | 528,00 | 0,00 | Derivative Exercise and Retained Stock | - | 9,48k | 5,90% |
| 2026-06-17 | Mr. Musa TariqIndependent Director | 4,20k | 0,00 | Derivative Exercise and Retained Stock | - | 13,00k | 47,78% |
| 2026-06-17 | Ms. Myrtle S. PotterIndependent Director | 4,20k | 0,00 | Derivative Exercise and Retained Stock | - | 22,53k | 22,94% |
| 2026-06-17 | Mr. Steve Edward KrognesIndependent Director | 4,20k | 0,00 | Derivative Exercise and Retained Stock | - | 14,43k | 41,12% |
| 2026-06-17 | Mr. Roberto Agostino MignoneIndependent Director | 4,20k | 0,00 | Derivative Exercise and Retained Stock | - | 8,95k | 88,47% |
| 2026-06-17 | Ms. Meghan V. JoyceInsider | 4,20k | 0,00 | Derivative Exercise and Retained Stock | - | 15,39k | 37,58% |
| 2026-06-17 | Dr. Manuel Hidalgo MedinaIndependent Director | 4,44k | 0,00 | Derivative Exercise and Retained Stock | - | 5,07k | 694,05% |
| 2026-06-17 | Ms. Vijaya GaddeIndependent Director | 4,20k | 0,00 | Derivative Exercise and Retained Stock | - | 28,52k | 17,29% |
| 2026-06-17 | Mr. Ian T. ClarkLead Independent Director | 5,09k | 0,00 | Derivative Exercise and Retained Stock | - | 8,07k | 171,16% |
| 2026-06-15 | Mr. Kumud KaliaChief Information Officer | -314,00 | 40,76k | Derivative Exercise and Sale | 129,82 | 41,41k | - |
| 2026-06-15 | Mr. Kumud KaliaChief Information Officer | 324,00 | 0,00 | Derivative Exercise and Retained Stock | - | 41,41k | 0,79% |
| 2026-06-15 | Mr. Musa TariqIndependent Director | -116,00 | 15,10k | Derivative Exercise and Sale | 130,19 | 8,80k | - |
| 2026-06-15 | Mr. Musa TariqIndependent Director | 134,00 | 0,00 | Derivative Exercise and Retained Stock | - | 8,80k | 1,55% |
| 2026-06-15 | Mr. Christopher FreemanChief Commercial Officer of Oncology | -594,00 | 77,11k | Derivative Exercise and Sale | 129,82 | 61,10k | - |
| 2026-06-15 | Mr. Christopher FreemanChief Commercial Officer of Oncology | 808,00 | 0,00 | Derivative Exercise and Retained Stock | - | 61,10k | 1,34% |
| 2026-06-15 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -535,00 | 69,45k | Derivative Exercise and Sale | 129,82 | 36,44k | - |
| 2026-06-15 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | 485,00 | 0,00 | Derivative Exercise and Retained Stock | - | 36,44k | 1,35% |
| 2026-06-15 | Mr. Michael BellCFO | -1,10k | 142,28k | Derivative Exercise and Sale | 129,82 | 48,45k | - |
| 2026-06-15 | Mr. Michael BellCFO | 943,00 | 0,00 | Derivative Exercise and Retained Stock | - | 48,45k | 1,98% |
| 2026-06-11 | Mr. Kumud KaliaChief Information Officer | -3,42k | 445,16k | Vendita | 130,24 | 41,09k | -7,68% |
| 2026-06-10 | Mr. Kumud KaliaChief Information Officer | -5,00k | 652,03k | Vendita | 130,41 | 44,51k | -10,10% |
| 2026-06-05 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | -100,00k | 12,63M | Vendita | 125,57 - 132,55 | 2,34M | -4,10% |
| 2026-06-05 | Mr. Michael BellCFO | -2,00k | 257,24k | Vendita | 128,62 | 47,51k | -4,04% |
| 2026-06-04 | Mr. Steve Edward KrognesIndependent Director | -9,29k | 1,23M | Vendita | 132,51 | 10,22k | -47,62% |
| 2026-06-03 | Ms. Meghan V. JoyceInsider | -10,00k | 889,26k | Derivative Exercise and Sale | 38,01 - 129,31 | 11,18k | - |
| 2026-05-31 | Mr. Steve Edward KrognesIndependent Director | 154,00 | 0,00 | Derivative Exercise and Retained Stock | - | 19,52k | 0,80% |
| 2026-05-28 | Dr. Manuel Hidalgo MedinaIndependent Director | -1.000,00 | 130,06k | Vendita | 130,06 | 639,00 | -61,01% |
| 2026-05-27 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -10,00k | 1,25M | Vendita | 125,08 - 126,08 | 35,95k | -21,76% |
| 2026-05-22 | Mr. Christopher FreemanChief Commercial Officer of Oncology | -24,41k | 2,09M | Derivative Exercise and Sale | 32,86 - 118,67 | 60,03k | - |
| 2026-05-20 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -20,00k | 2,13M | Vendita | 105,34 - 107,23 | 45,95k | -30,33% |
| 2026-05-20 | Dr. AmirAli TalasazCo-CEO & Director | -210,00k | 23,08M | Vendita | 100,95 - 112,76 | 1,89M | -10,02% |
| 2026-05-20 | Dr. Manuel Hidalgo MedinaIndependent Director | -250,00 | 26,77k | Vendita | 107,07 | 1,64k | -13,23% |
| 2026-05-20 | Dr. Manuel Hidalgo MedinaIndependent Director | -1.000,00 | 74,55k | Derivative Exercise and Sale | 32,55 - 107,10 | 1,64k | - |
| 2026-05-20 | Mr. Ian T. ClarkLead Independent Director | -6,88k | 735,05k | Vendita | 106,90 | 2,98k | -69,80% |
| 2026-05-15 | Mr. Musa TariqIndependent Director | -116,00 | 11,13k | Derivative Exercise and Sale | 95,96 | 8,66k | - |
| 2026-05-15 | Mr. Musa TariqIndependent Director | 134,00 | 0,00 | Derivative Exercise and Retained Stock | - | 8,66k | 1,57% |
| 2026-05-17 | Dr. Manuel Hidalgo MedinaIndependent Director | 232,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,89k | 14,00% |
| 2026-05-15 | Dr. Darya ChudovaCTO | -4,68k | 444,13k | Derivative Exercise and Sale | 94,92 | 83,94k | - |
| 2026-05-15 | Dr. Darya ChudovaCTO | 4,03k | 0,00 | Derivative Exercise and Retained Stock | - | 83,94k | 5,04% |
| 2026-05-12 | Dr. AmirAli TalasazCo-CEO & Director | -50,00k | 5,02M | Vendita | 100,32 | 2,10M | -2,33% |
| 2026-04-30 | Mr. Steve Edward KrognesIndependent Director | 154,00 | 0,00 | Derivative Exercise and Retained Stock | - | 19,36k | 0,80% |
| 2026-04-21 | Mr. Roberto Agostino MignoneIndependent Director | 264,00 | 0,00 | Derivative Exercise and Retained Stock | - | 4,75k | 5,88% |
| 2026-04-17 | Dr. Manuel Hidalgo MedinaIndependent Director | 232,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,66k | 16,28% |
| 2026-04-15 | Mr. Musa TariqIndependent Director | 134,00 | 0,00 | Derivative Exercise and Retained Stock | - | 8,53k | 1,60% |
| 2026-04-15 | Mr. Musa TariqIndependent Director | -116,00 | 9,84k | Derivative Exercise and Sale | 84,83 | 8,53k | - |
| 2026-04-15 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | 3,60k | 0,00 | Derivative Exercise and Retained Stock | - | 65,95k | 5,77% |
| 2026-04-15 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -3,97k | 336,89k | Derivative Exercise and Sale | 84,86 | 65,95k | - |
| 2026-04-06 | Ms. Terilyn Juarez MonroeCPO | -3,83k | 355,15k | Vendita | 92,68 | 20,99k | -15,44% |
| 2026-04-01 | Ms. Terilyn Juarez MonroeCPO | 3,83k | 0,00 | Derivative Exercise and Retained Stock | - | 24,82k | 18,26% |
| 2026-04-01 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | 5,45k | 0,00 | Derivative Exercise and Retained Stock | - | 62,35k | 9,57% |
| 2026-04-01 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -6,01k | 548,08k | Derivative Exercise and Sale | 91,15 | 62,35k | - |
| 2026-04-01 | Ms. Terilyn Juarez MonroeCPO | -4,19k | 381,65k | Derivative Exercise and Sale | 91,15 | 24,82k | - |
| 2026-04-01 | Mr. Kumud KaliaChief Information Officer | 4,95k | 0,00 | Derivative Exercise and Retained Stock | - | 49,25k | 11,18% |
| 2026-04-01 | Mr. Kumud KaliaChief Information Officer | -5,09k | 464,14k | Derivative Exercise and Sale | 91,15 | 49,25k | - |
| 2026-04-01 | Dr. Craig EagleInsider | 5,62k | 0,00 | Derivative Exercise and Retained Stock | - | 72,00k | 8,47% |
| 2026-04-01 | Mr. Christopher FreemanChief Commercial Officer of Oncology | 6,46k | 0,00 | Derivative Exercise and Retained Stock | - | 60,03k | 12,06% |
| 2026-04-01 | Mr. Christopher FreemanChief Commercial Officer of Oncology | -4,75k | 432,96k | Derivative Exercise and Sale | 91,15 | 60,03k | - |
| 2026-04-01 | Dr. Craig EagleInsider | -5,78k | 526,76k | Derivative Exercise and Sale | 91,15 | 72,00k | - |
| 2026-04-01 | Mr. Michael BellCFO | 5,91k | 0,00 | Derivative Exercise and Retained Stock | - | 49,51k | 13,55% |
| 2026-04-01 | Mr. Michael BellCFO | -6,87k | 626,11k | Derivative Exercise and Sale | 91,15 | 49,51k | - |
| 2026-04-01 | Dr. Darya ChudovaCTO | 6,02k | 0,00 | Derivative Exercise and Retained Stock | - | 79,91k | 8,15% |
| 2026-04-01 | Dr. Darya ChudovaCTO | -7,01k | 638,51k | Derivative Exercise and Sale | 91,15 | 79,91k | - |
| 2026-03-31 | Dr. AmirAli TalasazCo-CEO & Director | 18,02k | 0,00 | Derivative Exercise and Retained Stock | - | 2,48M | 0,73% |
| 2026-03-31 | Dr. AmirAli TalasazCo-CEO & Director | -18,52k | 1,69M | Derivative Exercise and Sale | 91,15 - 92,37 | 2,48M | - |
| 2026-03-31 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | 18,02k | 0,00 | Derivative Exercise and Retained Stock | - | 2,44M | 0,74% |
| 2026-03-31 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | -18,52k | 1,69M | Derivative Exercise and Sale | 91,15 - 92,37 | 2,44M | - |
| 2026-03-31 | Mr. Steve Edward KrognesIndependent Director | 155,00 | 0,00 | Derivative Exercise and Retained Stock | - | 19,21k | 0,81% |
| 2026-03-21 | Mr. Roberto Agostino MignoneIndependent Director | 264,00 | 0,00 | Derivative Exercise and Retained Stock | - | 4,49k | 6,25% |
| 2026-03-18 | Mr. Musa TariqIndependent Director | -348,00 | 30,66k | Vendita | 88,09 | 8,39k | -3,98% |
| 2026-03-17 | Dr. Manuel Hidalgo MedinaIndependent Director | 232,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,43k | 19,45% |
| 2026-01-01 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | 32,18k | 0,00 | Derivative Exercise and Retained Stock | - | 2,42M | 1,35% |
| 2026-01-01 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | -33,07k | 3,15M | Derivative Exercise and Sale | 85,49 - 102,14 | 2,42M | - |
| 2026-01-01 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | -13,21k | 0,00 | Other Disposition | - | 2,42M | -0,54% |
| 2026-01-01 | Dr. AmirAli TalasazCo-CEO & Director | 32,18k | 0,00 | Derivative Exercise and Retained Stock | - | 2,46M | 1,32% |
| 2026-01-01 | Dr. AmirAli TalasazCo-CEO & Director | -33,07k | 3,15M | Derivative Exercise and Sale | 85,49 - 102,14 | 2,46M | - |
| 2026-01-01 | Dr. AmirAli TalasazCo-CEO & Director | -13,21k | 0,00 | Other Disposition | - | 2,46M | -0,53% |
| 2026-03-15 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | 4,19k | 0,00 | Derivative Exercise and Retained Stock | - | 56,90k | 7,95% |
| 2026-03-15 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -4,62k | 395,13k | Derivative Exercise and Sale | 85,49 | 56,90k | - |
| 2026-03-15 | Mr. Kumud KaliaChief Information Officer | 6,65k | 0,00 | Derivative Exercise and Retained Stock | - | 44,30k | 17,68% |
| 2026-03-15 | Mr. Kumud KaliaChief Information Officer | -6,84k | 584,67k | Derivative Exercise and Sale | 85,49 | 44,30k | - |
| 2026-03-15 | Mr. Musa TariqIndependent Director | 249,00 | 0,00 | Derivative Exercise and Retained Stock | - | 8,74k | 2,93% |
| 2026-03-15 | Mr. Christopher FreemanChief Commercial Officer of Oncology | 9,70k | 0,00 | Derivative Exercise and Retained Stock | - | 53,57k | 22,11% |
| 2026-03-15 | Mr. Christopher FreemanChief Commercial Officer of Oncology | -7,13k | 609,29k | Derivative Exercise and Sale | 85,49 | 53,57k | - |
| 2026-03-15 | Dr. Craig EagleInsider | 7,45k | 0,00 | Derivative Exercise and Retained Stock | - | 66,38k | 12,65% |
| 2026-03-15 | Dr. Craig EagleInsider | -7,66k | 654,94k | Derivative Exercise and Sale | 85,49 | 66,38k | - |
| 2026-03-15 | Dr. Darya ChudovaCTO | 4,96k | 0,00 | Derivative Exercise and Retained Stock | - | 73,89k | 7,19% |
| 2026-03-15 | Dr. Darya ChudovaCTO | -5,76k | 492,34k | Derivative Exercise and Sale | 85,49 | 73,89k | - |
| 2026-03-15 | Mr. Michael BellCFO | 3,38k | 0,00 | Derivative Exercise and Retained Stock | - | 43,60k | 8,40% |
| 2026-03-15 | Mr. Michael BellCFO | -10,41k | 894,85k | Derivative Exercise and Sale | 85,49 - 87,04 | 43,60k | - |
| 2026-03-06 | Dr. Manuel Hidalgo MedinaIndependent Director | -1.000,00 | 59,06k | Derivative Exercise and Sale | 32,55 - 91,61 | 1,19k | - |
| 2026-03-06 | Dr. Manuel Hidalgo MedinaIndependent Director | -300,00 | 27,39k | Vendita | 91,30 | 1,19k | -20,09% |
| 2026-03-04 | Mr. Kumud KaliaChief Information Officer | 3,12k | 147,22k | Derivative Exercise and Retained Stock | 47,20 | 37,64k | 9,03% |
| 2026-03-04 | Mr. Kumud KaliaChief Information Officer | -40,00k | 2,34M | Derivative Exercise and Sale | 28,37 - 95,73 | 37,64k | - |
| 2026-02-28 | Mr. Steve Edward KrognesIndependent Director | 154,00 | 0,00 | Derivative Exercise and Retained Stock | - | 19,05k | 0,81% |
| 2026-02-21 | Mr. Roberto Agostino MignoneIndependent Director | 264,00 | 0,00 | Derivative Exercise and Retained Stock | - | 4,22k | 6,67% |
| 2026-02-17 | Dr. Manuel Hidalgo MedinaIndependent Director | 232,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,49k | 18,40% |
| 2026-02-15 | Mr. Musa TariqIndependent Director | 250,00 | 0,00 | Derivative Exercise and Retained Stock | - | 8,49k | 3,03% |
| 2026-01-31 | Mr. Steve Edward KrognesIndependent Director | 154,00 | 0,00 | Derivative Exercise and Retained Stock | - | 18,90k | 0,82% |
| 2026-01-21 | Mr. Roberto Agostino MignoneIndependent Director | 264,00 | 0,00 | Derivative Exercise and Retained Stock | - | 3,96k | 7,14% |
| 2026-01-21 | Ms. Terilyn Juarez MonroeCPO | -8,57k | 977,90k | Vendita | 112,34 - 115,70 | 20,99k | -28,99% |
| 2025-12-31 | Dr. AmirAli TalasazCo-CEO & Director | -2,08M | 0,00 | Other Disposition | - | 2,43M | -46,13% |
| 2025-12-31 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | -2,05M | 0,00 | Other Disposition | - | 2,39M | -46,15% |
| 2025-12-08 | Dr. Darya ChudovaCTO | -47,92k | 0,00 | Other Disposition | - | 68,94k | -41,01% |
| 2026-01-17 | Dr. Manuel Hidalgo MedinaIndependent Director | 232,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,26k | 22,55% |
| 2026-01-15 | Mr. Musa TariqIndependent Director | 250,00 | 0,00 | Derivative Exercise and Retained Stock | - | 8,24k | 3,13% |
| 2026-01-15 | Ms. Terilyn Juarez MonroeCPO | 8,57k | 0,00 | Derivative Exercise and Retained Stock | - | 29,56k | 40,83% |
| 2026-01-15 | Ms. Terilyn Juarez MonroeCPO | -8,81k | 986,32k | Derivative Exercise and Sale | 111,98 | 29,56k | - |
| 2026-01-07 | Ms. Terilyn Juarez MonroeCPO | -10,03k | 1,12M | Vendita | 111,75 - 113,44 | 20,99k | -32,34% |
| 2026-01-01 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | 9,06k | 0,00 | Derivative Exercise and Retained Stock | - | 52,71k | 20,75% |
| 2026-01-01 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -9,99k | 1,02M | Derivative Exercise and Sale | 102,14 | 52,71k | - |
| 2026-01-01 | Ms. Terilyn Juarez MonroeCPO | 10,03k | 0,00 | Derivative Exercise and Retained Stock | - | 31,02k | 47,79% |
| 2026-01-01 | Ms. Terilyn Juarez MonroeCPO | -7,52k | 768,50k | Derivative Exercise and Sale | 102,14 | 31,02k | - |
| 2026-01-01 | Mr. Kumud KaliaChief Information Officer | 11,85k | 0,00 | Derivative Exercise and Retained Stock | - | 34,52k | 52,23% |
| 2026-01-01 | Mr. Kumud KaliaChief Information Officer | -9,39k | 959,30k | Derivative Exercise and Sale | 102,14 | 34,52k | - |
| 2026-01-01 | Mr. Christopher FreemanChief Commercial Officer of Oncology | 17,08k | 0,00 | Derivative Exercise and Retained Stock | - | 43,87k | 63,72% |
| 2026-01-01 | Mr. Christopher FreemanChief Commercial Officer of Oncology | -10,16k | 1,04M | Derivative Exercise and Sale | 102,14 | 43,87k | - |
| 2026-01-01 | Dr. Craig EagleInsider | 13,92k | 0,00 | Derivative Exercise and Retained Stock | - | 58,93k | 30,93% |
| 2026-01-01 | Dr. Craig EagleInsider | -11,52k | 1,18M | Derivative Exercise and Sale | 102,14 | 58,93k | - |
| 2026-01-01 | Dr. Darya ChudovaCTO | 10,42k | 0,00 | Derivative Exercise and Retained Stock | - | 71,91k | 16,94% |
| 2026-01-01 | Dr. Darya ChudovaCTO | -12,32k | 1,26M | Derivative Exercise and Sale | 102,14 | 71,91k | - |
| 2026-01-01 | Mr. Michael BellCFO | 10,56k | 0,00 | Derivative Exercise and Retained Stock | - | 40,22k | 35,59% |
| 2026-01-01 | Mr. Michael BellCFO | -12,48k | 1,27M | Derivative Exercise and Sale | 102,14 | 40,22k | - |
| 2025-12-31 | Dr. AmirAli TalasazCo-CEO & Director | 15,58k | 0,00 | Derivative Exercise and Retained Stock | - | 2,01M | 0,78% |
| 2025-12-31 | Dr. AmirAli TalasazCo-CEO & Director | -13,23k | 1,35M | Derivative Exercise and Sale | 102,14 | 2,01M | - |
| 2025-12-31 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | 15,58k | 0,00 | Derivative Exercise and Retained Stock | - | 2,39M | 0,66% |
| 2025-12-31 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | -13,23k | 1,35M | Derivative Exercise and Sale | 102,14 | 2,39M | - |
| 2025-12-31 | Mr. Steve Edward KrognesIndependent Director | 154,00 | 0,00 | Derivative Exercise and Retained Stock | - | 18,75k | 0,83% |
| 2025-12-21 | Mr. Roberto Agostino MignoneIndependent Director | 264,00 | 0,00 | Derivative Exercise and Retained Stock | - | 3,70k | 7,69% |
| 2025-12-17 | Mr. Musa TariqIndependent Director | -116,00 | 11,77k | Vendita | 101,46 | 7,99k | -1,43% |
| 2025-12-17 | Dr. Manuel Hidalgo MedinaIndependent Director | 232,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,03k | 29,11% |
| 2025-12-15 | Mr. Musa TariqIndependent Director | 250,00 | 0,00 | Derivative Exercise and Retained Stock | - | 8,11k | 3,18% |
| 2025-12-15 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | 485,00 | 0,00 | Derivative Exercise and Retained Stock | - | 43,66k | 1,12% |
| 2025-12-15 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -535,00 | 54,93k | Derivative Exercise and Sale | 102,67 | 43,66k | - |
| 2025-12-15 | Mr. Christopher FreemanChief Commercial Officer of Oncology | 808,00 | 0,00 | Derivative Exercise and Retained Stock | - | 26,80k | 3,11% |
| 2025-12-15 | Mr. Christopher FreemanChief Commercial Officer of Oncology | -594,00 | 60,99k | Derivative Exercise and Sale | 102,67 | 26,80k | - |
| 2025-12-15 | Mr. Kumud KaliaChief Information Officer | 314,00 | 0,00 | Derivative Exercise and Retained Stock | - | 22,68k | 1,40% |
| 2025-12-15 | Mr. Kumud KaliaChief Information Officer | -323,00 | 33,16k | Derivative Exercise and Sale | 102,67 | 22,68k | - |
| 2025-12-15 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | -90,57k | 9,40M | Vendita | 103,80 - 104,02 | 2,38M | -3,67% |
| 2025-12-15 | Dr. Craig EagleInsider | 691,00 | 0,00 | Derivative Exercise and Retained Stock | - | 45,01k | 1,56% |
| 2025-12-15 | Dr. Craig EagleInsider | -711,00 | 73,00k | Derivative Exercise and Sale | 102,67 | 45,01k | - |
| 2025-12-15 | Dr. Darya ChudovaCTO | -5,45k | 567,13k | Vendita | 104,04 | 61,49k | -8,14% |
| 2025-12-15 | Mr. Michael BellCFO | 1,61k | 0,00 | Derivative Exercise and Retained Stock | - | 29,67k | 5,75% |
| 2025-12-15 | Mr. Michael BellCFO | -1,66k | 170,33k | Derivative Exercise and Sale | 102,67 | 29,67k | - |
| 2025-12-08 | Mr. Kumud KaliaChief Information Officer | -2,00k | 209,20k | Vendita | 104,60 | 22,37k | -8,21% |
| 2025-12-08 | Dr. AmirAli TalasazCo-CEO & Director | -387,95k | 0,00 | Other Disposition | - | 2,42M | -13,83% |
| 2025-12-08 | Dr. AmirAli TalasazCo-CEO & Director | -100,00k | 10,51M | Vendita | 104,21 - 106,00 | 2,42M | -3,97% |
| 2025-12-08 | Dr. Manuel Hidalgo MedinaIndependent Director | -1.000,00 | 72,45k | Derivative Exercise and Sale | 32,55 - 105,00 | 797,00 | - |
| 2025-12-08 | Dr. Manuel Hidalgo MedinaIndependent Director | -250,00 | 26,25k | Vendita | 105,00 | 797,00 | -23,88% |
| 2025-12-08 | Dr. Darya ChudovaCTO | -22,94k | 2,42M | Vendita | 105,04 - 106,00 | 66,94k | -25,52% |
| 2025-12-08 | Dr. Darya ChudovaCTO | -68,14k | 0,00 | Other Disposition | - | 66,94k | -50,44% |
| 2025-12-05 | Mr. Christopher FreemanChief Commercial Officer of Oncology | -31,45k | 3,24M | Vendita | 101,40 - 106,71 | 25,99k | -54,76% |
| 2025-12-05 | Mr. Michael BellCFO | -56,29k | 4,07M | Derivative Exercise and Sale | 28,37 - 106,68 | 28,05k | - |
| 2025-12-05 | Mr. Michael BellCFO | -24,08k | 2,49M | Vendita | 101,46 - 107,26 | 28,05k | -46,19% |
| 2025-12-05 | Mr. Ian T. ClarkLead Independent Director | -28,61k | 2,04M | Derivative Exercise and Sale | 31,84 - 108,05 | 9,85k | - |
| 2025-12-01 | Ms. Terilyn Juarez MonroeCPO | -50,00k | 4,16M | Derivative Exercise and Sale | 20,14 - 107,85 | 20,92k | - |
| 2025-12-01 | Ms. Terilyn Juarez MonroeCPO | -5,17k | 547,68k | Vendita | 105,33 - 107,03 | 20,92k | -19,81% |
| 2025-11-30 | Mr. Steve Edward KrognesIndependent Director | 155,00 | 0,00 | Derivative Exercise and Retained Stock | - | 18,59k | 0,84% |
| 2025-11-21 | Mr. Roberto Agostino MignoneIndependent Director | 264,00 | 0,00 | Derivative Exercise and Retained Stock | - | 3,43k | 8,34% |
| 2025-11-19 | Mr. Musa TariqIndependent Director | -116,00 | 11,17k | Vendita | 96,25 | 7,86k | -1,45% |
| 2025-11-17 | Dr. Manuel Hidalgo MedinaIndependent Director | 232,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,05k | 28,47% |
| 2025-11-15 | Mr. Musa TariqIndependent Director | 250,00 | 0,00 | Derivative Exercise and Retained Stock | - | 7,98k | 3,24% |
| 2025-11-07 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -9,00k | 865,87k | Vendita | 96,25 | 43,17k | -17,24% |
| 2025-11-07 | Dr. Manuel Hidalgo MedinaIndependent Director | -1.000,00 | 62,62k | Derivative Exercise and Sale | 32,55 - 95,17 | 815,00 | - |
| 2025-11-07 | Dr. Manuel Hidalgo MedinaIndependent Director | -500,00 | 47,62k | Vendita | 95,23 | 815,00 | -38,02% |
| 2025-10-31 | Mr. Steve Edward KrognesIndependent Director | 154,00 | 0,00 | Derivative Exercise and Retained Stock | - | 18,44k | 0,84% |
| 2025-10-21 | Mr. Roberto Agostino MignoneIndependent Director | 3,17k | 0,00 | Derivative Exercise and Retained Stock | - | 3,17k | - |
| 2025-10-17 | Dr. Manuel Hidalgo MedinaIndependent Director | 232,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,32k | 21,42% |
| 2025-10-17 | Mr. Musa TariqIndependent Director | -116,00 | 7,77k | Vendita | 66,95 | 7,73k | -1,48% |
| 2025-10-17 | Ms. Myrtle S. PotterIndependent Director | -26,00 | 1,74k | Vendita | 66,95 | 18,32k | -0,14% |
| 2025-10-01 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | 6,74k | 0,00 | Derivative Exercise and Retained Stock | - | 52,17k | 14,83% |
| 2025-10-01 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -7,43k | 465,55k | Derivative Exercise and Sale | 62,65 | 52,17k | - |
| 2025-10-01 | Mr. Kumud KaliaChief Information Officer | 5,20k | 0,00 | Derivative Exercise and Retained Stock | - | 24,37k | 27,14% |
| 2025-10-01 | Mr. Kumud KaliaChief Information Officer | -5,35k | 335,05k | Derivative Exercise and Sale | 62,65 | 24,37k | - |
| 2025-10-01 | Ms. Terilyn Juarez MonroeCPO | 5,17k | 0,00 | Derivative Exercise and Retained Stock | - | 26,09k | 24,70% |
| 2025-10-01 | Ms. Terilyn Juarez MonroeCPO | -5,31k | 332,67k | Derivative Exercise and Sale | 62,65 | 26,09k | - |
| 2025-10-01 | Dr. Craig EagleInsider | 6,83k | 0,00 | Derivative Exercise and Retained Stock | - | 44,32k | 18,23% |
| 2025-10-01 | Dr. Craig EagleInsider | -7,03k | 440,12k | Derivative Exercise and Sale | 62,65 | 44,32k | - |
| 2025-10-01 | Dr. Darya ChudovaCTO | 7,94k | 0,00 | Derivative Exercise and Retained Stock | - | 89,39k | 9,75% |
| 2025-10-01 | Dr. Darya ChudovaCTO | -8,16k | 511,41k | Derivative Exercise and Sale | 62,65 | 89,39k | - |
| 2025-10-01 | Mr. Christopher FreemanChief Commercial Officer of Oncology | 7,81k | 0,00 | Derivative Exercise and Retained Stock | - | 57,44k | 15,74% |
| 2025-10-01 | Mr. Christopher FreemanChief Commercial Officer of Oncology | -5,74k | 359,61k | Derivative Exercise and Sale | 62,65 | 57,44k | - |
| 2025-09-30 | Mr. Steve Edward KrognesIndependent Director | 154,00 | 0,00 | Derivative Exercise and Retained Stock | - | 18,28k | 0,85% |
| 2025-10-01 | Mr. Michael BellCFO | 7,49k | 0,00 | Derivative Exercise and Retained Stock | - | 52,13k | 16,77% |
| 2025-10-01 | Mr. Michael BellCFO | -7,70k | 482,09k | Derivative Exercise and Sale | 62,65 | 52,13k | - |
| 2025-09-30 | Dr. AmirAli TalasazCo-CEO & Director | 14,21k | 0,00 | Derivative Exercise and Retained Stock | - | 2,52M | 0,57% |
| 2025-09-30 | Dr. AmirAli TalasazCo-CEO & Director | -14,60k | 914,40k | Derivative Exercise and Sale | 62,48 - 62,65 | 2,52M | - |
| 2025-09-30 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | 14,21k | 0,00 | Derivative Exercise and Retained Stock | - | 2,47M | 0,58% |
| 2025-09-30 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | -14,60k | 914,40k | Derivative Exercise and Sale | 62,48 - 62,65 | 2,47M | - |
| 2025-09-17 | Dr. Manuel Hidalgo MedinaIndependent Director | 232,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,08k | 27,26% |
| 2025-09-15 | Mr. Musa TariqIndependent Director | 133,00 | 0,00 | Derivative Exercise and Retained Stock | - | 7,59k | 1,78% |
| 2025-09-15 | Mr. Musa TariqIndependent Director | -116,00 | 6,45k | Derivative Exercise and Sale | 55,63 | 7,59k | - |
| 2025-09-15 | Ms. Myrtle S. PotterIndependent Director | 42,00 | 0,00 | Derivative Exercise and Retained Stock | - | 18,28k | 0,23% |
| 2025-09-15 | Ms. Myrtle S. PotterIndependent Director | -26,00 | 1,45k | Derivative Exercise and Sale | 55,63 | 18,28k | - |
| 2025-09-15 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | 484,00 | 0,00 | Derivative Exercise and Retained Stock | - | 45,43k | 1,08% |
| 2025-09-15 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -535,00 | 29,31k | Derivative Exercise and Sale | 54,79 | 45,43k | - |
| 2025-09-15 | Mr. Kumud KaliaChief Information Officer | 314,00 | 0,00 | Derivative Exercise and Retained Stock | - | 19,16k | 1,67% |
| 2025-09-15 | Mr. Kumud KaliaChief Information Officer | -324,00 | 17,75k | Derivative Exercise and Sale | 54,79 | 19,16k | - |
| 2025-09-15 | Dr. Craig EagleInsider | 691,00 | 0,00 | Derivative Exercise and Retained Stock | - | 37,48k | 1,88% |
| 2025-09-15 | Dr. Craig EagleInsider | -711,00 | 38,96k | Derivative Exercise and Sale | 54,79 | 37,48k | - |
| 2025-09-15 | Mr. Christopher FreemanChief Commercial Officer of Oncology | 808,00 | 0,00 | Derivative Exercise and Retained Stock | - | 49,63k | 1,66% |
| 2025-09-15 | Mr. Christopher FreemanChief Commercial Officer of Oncology | -594,00 | 32,55k | Derivative Exercise and Sale | 54,79 | 49,63k | - |
| 2025-09-15 | Mr. Michael BellCFO | 1,61k | 0,00 | Derivative Exercise and Retained Stock | - | 44,64k | 3,75% |
| 2025-09-15 | Mr. Michael BellCFO | -1,66k | 90,90k | Derivative Exercise and Sale | 54,79 | 44,64k | - |
| 2025-09-12 | Dr. Manuel Hidalgo MedinaIndependent Director | -2,17k | 117,25k | Vendita | 54,16 | 851,00 | -71,78% |
| 2025-09-09 | Dr. Helmy EltoukhyCo-Founder, Co-CEO & Chairman | -300,00k | 17,84M | Vendita | 59,44 - 59,93 | 2,45M | -10,90% |
| 2025-09-02 | Ms. Meghan V. JoyceInsider | -100,00 | 6,58k | Vendita | 65,84 | 11,18k | -0,89% |
| 2025-09-01 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | 125,00 | 0,00 | Derivative Exercise and Retained Stock | - | 44,95k | 0,28% |
| 2025-09-01 | Mr. John G. SaiaChief Legal Officer & Corporate Secretary | -139,00 | 9,37k | Derivative Exercise and Sale | 67,42 | 44,95k | - |
| 2025-09-01 | Mr. Kumud KaliaChief Information Officer | 350,00 | 0,00 | Derivative Exercise and Retained Stock | - | 18,85k | 1,89% |
| 2025-09-01 | Mr. Kumud KaliaChief Information Officer | -361,00 | 24,34k | Derivative Exercise and Sale | 67,42 | 18,85k | - |
| 2025-09-01 | Dr. Darya ChudovaCTO | 155,00 | 0,00 | Derivative Exercise and Retained Stock | - | 81,45k | 0,19% |
| 2025-09-01 | Dr. Darya ChudovaCTO | -161,00 | 10,85k | Derivative Exercise and Sale | 67,42 | 81,45k | - |
| 2025-08-31 | Mr. Steve Edward KrognesIndependent Director | 155,00 | 0,00 | Derivative Exercise and Retained Stock | - | 18,13k | 0,86% |
| 2025-08-21 | Mr. Kumud KaliaChief Information Officer | -2,00k | 123,51k | Vendita | 61,76 | 18,50k | -9,76% |
| 2025-08-19 | Mr. Musa TariqIndependent Director | -116,00 | 6,85k | Vendita | 59,02 | 7,46k | -1,53% |
| 2025-08-19 | Ms. Myrtle S. PotterIndependent Director | -26,00 | 1,53k | Vendita | 59,02 | 18,24k | -0,14% |
| 2025-08-17 | Dr. Manuel Hidalgo MedinaIndependent Director | 232,00 | 0,00 | Derivative Exercise and Retained Stock | - | 3,02k | 8,33% |
| 2025-08-15 | Mr. Musa TariqIndependent Director | 250,00 | 0,00 | Derivative Exercise and Retained Stock | - | 7,57k | 3,41% |
| 2025-08-15 | Ms. Myrtle S. PotterIndependent Director | 69,00 | 0,00 | Derivative Exercise and Retained Stock | - | 18,27k | 0,38% |
| 2025-08-04 | Ms. Meghan V. JoyceInsider | 67,00 | 0,00 | Derivative Exercise and Retained Stock | - | 11,28k | 0,60% |
| 2025-07-31 | Mr. Steve Edward KrognesIndependent Director | 154,00 | 0,00 | Derivative Exercise and Retained Stock | - | 17,97k | 0,86% |
| 2025-07-17 | Mr. Musa TariqIndependent Director | -116,00 | 5,59k | Vendita | 48,20 | 7,32k | -1,56% |
| 2025-07-17 | Ms. Myrtle S. PotterIndependent Director | -26,00 | 1,25k | Vendita | 48,20 | 18,20k | -0,14% |
| 2025-07-17 | Dr. Manuel Hidalgo MedinaIndependent Director | 2,78k | 0,00 | Derivative Exercise and Retained Stock | - | 2,78k | - |
| 2025-07-15 | Mr. Musa TariqIndependent Director | 250,00 | 0,00 | Derivative Exercise and Retained Stock | - | 7,44k | 3,48% |
| 2025-07-15 | Ms. Myrtle S. PotterIndependent Director | 68,00 | 0,00 | Derivative Exercise and Retained Stock | - | 18,22k | 0,37% |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
